Articles

2020 Women of Influence: Candy Gee

Candy Gee is responsible for advancing the Roche Diagnostics’ focus on diverse talent acquisition and development, building external partnerships, developing sustainable diversity and inclusion strategies and processes, and employee education.

Read More

2020 Women of Influence: Kathy Martin Harrison

Kathy Martin Harrison’s company, Ed Martin Automotive Group, was the largest woman-owned business in Indianapolis last year, according to IBJ research. It owns nine car dealerships representing 12 manufacturers in Indianapolis, Carmel, Fishers, Noblesville and Anderson.

Read More

2020 Women of Influence: Michelle A. Janney

Janney oversees the operations of IU Health, the state’s largest health care system, with 16 hospitals, and its second-largest private employer, with more than 34,000 team members and more than 2,500 physicians. And this year, she took on an unexpected but important role: incident commander of the COVID-19 emergency response team for IU Health.

Read More

2020 Women of Influence: Donna Kelsey

Donna Kelsey, a 26-year veteran of the U.S. Navy and U.S. Naval Reserve, took over at American Senior Communities amid a crisis at the company. She reorganized the company, prioritizing the care of the residents and adding controls to guard against the fraud that had felled her predecessor.

Read More

2020 Women of Influence: Sarena Lin

Sarena Lin, who joined Elanco Animal Health three years ago, leads the company’s ongoing separation from former parent Eli Lilly and Co. and is simultaneously leading the integration into the company of Bayer Animal Health, which Elanco acquired this year for $7.6 billion.

Read More

2018 WOMAN OF INFLUENCE: Melissa St. John

Melissa St. John’s company specializes in corporate moves and has a long list of prominent clients, but the awards she’s received have as much to do with corporate citizenship as with the bottom line.

Read More

2018 WOMAN OF INFLUENCE: Christi Shaw

Working at Eli Lilly and Co. right out of college, Christi Shaw went on to other major drug companies before returning to head a division that represents about 40 percent of Lilly’s worldwide revenue.

Read More